Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease von willebrand disease
Phenotype C0018799|heart disease
Sentences 2
PubMedID- 24431031 Other independent studies demonstrated a beneficial effect of the c34t mutation on metabolic aspects related to the cardiovascular system such as a lower level of an inhibitor of plasminogen activator and soluble von willebrand factor in patients with coronary heart disease [8].
PubMedID- 23408959 We aimed to assess associations of circulating tissue plasminogen activator (t-pa) antigen, d-dimer and von willebrand factor (vwf) with coronary heart disease risk.

Page: 1